Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization

2015 ◽  
Vol 55 (6) ◽  
pp. 647-656 ◽  
Author(s):  
Manoj Khurana ◽  
Jayabharathi Vaidyanathan ◽  
Anshu Marathe ◽  
Nitin Mehrotra ◽  
Chandrahas G. Sahajwalla ◽  
...  
Keyword(s):  
Clinical Pharmacology ◽  
Renal Impairment ◽  
Dose Optimization ◽  
Quantitative Clinical Pharmacology

Clinical Pharmacology Studies in Patients with Renal Impairment: Past Experience and Regulatory Perspectives

2000 ◽  
Vol 40 (1) ◽  
pp. 31-38 ◽  
Author(s):  
S. Ibrahim ◽  
P. Honig ◽  
S-M. Huang ◽  
W. Gillespie ◽  
L.J. Lesko ◽  
...  
Keyword(s):  
Clinical Pharmacology ◽  
Renal Impairment ◽  
Past Experience

scholarly journals Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling

2016 ◽  
Vol 44 (7) ◽  
pp. 924-933 ◽  
Author(s):  
N. Mehrotra ◽  
A. Bhattaram ◽  
J. C. Earp ◽  
J. Florian ◽  
K. Krudys ◽  
...  
Keyword(s):  
Clinical Pharmacology ◽  
Quantitative Clinical Pharmacology

scholarly journals Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period

2016 ◽  
Vol 12 (4) ◽  
pp. 367-375 ◽  
Author(s):  
Janko Samardzic ◽  
Karel Allegaert ◽  
Mélanie Wilbaux ◽  
Marc Pfister ◽  
John N. van den Anker
Keyword(s):  
Clinical Pharmacology ◽  
Neonatal Period ◽  
Quantitative Clinical Pharmacology

Letter to the editor regarding: “Pharmacokinetics of teneligliptin in subjects with renal impairment.” Halabiet al.,Clinical Pharmacology in Drug Development2013;2:246-254

2014 ◽  
Vol 3 (5) ◽  
pp. 417-418
Author(s):  
Ulrike Graefe-Mody ◽  
Christian Friedrich ◽  
Maximilian von Eynatten ◽  
Sandra Thiemann ◽  
Tim Heise ◽  
...  
Keyword(s):  
Clinical Pharmacology ◽  
Renal Impairment ◽  
Letter To The Editor
Sign in / Sign up

Export Citation Format

Share Document